Previous close | 57.16 |
Open | 57.42 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 57.42 - 58.56 |
52-week range | 50.67 - 62.55 |
Volume | |
Avg. volume | 24 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
PARIS (Reuters) -French food group Danone will step up its focus on health and medical nutrition as it seeks to grow sales and boost cash generation from 2025 to 2028, the company said on Thursday. The maker of Activia yoghurt, Evian water and Aptamil baby food expects to achieve annual like-for-like net sales growth of 3-5% for that period, in line with the target it set for 2024. That should allow Danone to deliver a double-digit return on invested capital (ROIC) and progress towards its long-term free cash flow target of 3 billion euros ($3.2 billion), it said ahead of a presentation to investors in Amsterdam.
Danone SA (DANOY) recently announced a dividend of $0.46 per share, payable on 2024-05-29, with the ex-dividend date set for 2024-05-01. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates. Using the data from GuruFocus, let's look into Danone SA's dividend performance and assess its sustainability.
From Nestle to Danone, food companies are seeing shoppers that want either premium or cheaper products, with less interest in items in the middle, particularly in developed markets like North America. The packaged goods industry has for over two years hit shoppers with higher prices, citing higher costs that started with the pandemic and were exacerbated by Russia's invasion of Ukraine. Everything from sunflower oil to freight has become more expensive, taking a toll on global supply chains and consumers struggling to make ends meet.